CSIMarket
 


Diamedica Therapeutics Inc   (DMAC)
Other Ticker:  
 


Diamedica Therapeutics Inc's ROI from its fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Diamedica Therapeutics Inc's ROI in the fourth quarter of 2023?
Diamedica Therapeutics Inc recorded a cumulative net loss of $-19 million during 12 months ending in the fourth quarter of 2023, resulting in a negative return on investment (ROI) of -40.07%.

Within the Healthcare sector 274 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Dec 31 2023 quarter, so far to 2445, from total ROI ranking in the third quarter of 2023 at 2773.

Definition and Formula of Return on Investment


Return On Investment (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Investment Change 60.42 % 58.58 % 58.41 % -33.72 % -
Y / Y Net Income Change - - - - -
Investment (TTM) in Millions 51 56 60 27 32
Return On Investment (TTM) -40.07 % -41.26 % -43.1 % -46.91 % -37.63 %
DMAC's Overall Ranking # 2445 # 2773 # 3760 # 3817 # 4132
Seq. Investment Change -8.22 % -6.89 % 121.09 % -15.1 % -9.27 %
Seq. Net Income Change - - - - -
Net Income (TTM) in Millions -19 -18 -17 -15 -14




Return On Investment DMAC's Ranking
Within: No.
Industry # 100
Sector # 275
Overall # 2445

Return On Investment Statistics
High Average Low
-31.99 %
-54.51 %
-97.95 %
(Jun 30 2022)   (Dec 31 2019)







Financial Statements
Diamedica Therapeutics Inc's IV. Quarter Investments $ 51 Millions DMAC's Balance sheet
Diamedica Therapeutics Inc's IV. Quarter Income $ -5 Millions Quarterly DMAC's Income Statement
DMAC's Income by Division See DMAC's Income by Division


DMAC Annual Return On Investment (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
Total Investments in Millions 51 32 44 26 8
Y / Y Investment Growth 60.42 % -27.71 % 69.23 % 241.53 % -55.31 %
Net Income in Millions -19 -14 -14 -12 -11
Y / Y Net Income Growth - - - - -
Annual Return On Investment -37.96 % -42.97 % -30.87 % -47.25 % -139.81 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
DMAC's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for DMAC's Competitors
Roi for Diamedica Therapeutics Inc's Suppliers
Return On Investment for DMAC's Customers

Other Ratios
DMAC's Roa DMAC's Inventory Turnover Ratio DMAC's Growth Rates DMAC's Dividend Statistics
DMAC's Profitability Ratios DMAC's Asset Turnover Ratio DMAC's Dividend Growth
DMAC's Roe DMAC's Valuation Ratios DMAC's Financial Strength Ratios DMAC's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2023, within Healthcare Sector ROI


Date modified: 2024-03-19T22:43:20+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com